Orrick represented Credit Suisse and Jefferies as underwriters for a follow-on public offering of 2,695,313 shares of common stock by Intercept Pharmaceuticals, Inc. (“Intercept”), including shares…
Intercept Pharmaceuticals’ $172.5 Million Follow-on Offering
